ReviewCureus2025
Remineralization Potential of Self-Assembling Peptides Versus Fluoride Agents in White Spot Lesions: A Systematic Review.
Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07664046 (A Three-arm Randomized Controlled Trial Evaluating the Effectiveness of Self- Assembling Peptide P11-4 in the Remineralization of Enamel Carious White Spot Lesions), which is not on this map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
A Three-arm Randomized Controlled Trial Evaluating the Effectiveness of Self- Assembling Peptide P11-4 in the Remineralization of Enamel Carious White Spot Lesions
Who cites it
3 citing papers in PubMed.
- Biomimetic Enamel Remineralization in Pediatric Dentistry: From Biological Principles to Clinical Evidence.Cureus · 2026Review
- Knowledge, Attitudes, and Practices of Dentists Regarding the Diagnosis and Management of White Spot Lesions.Dentistry journal · 2026Article
- CaAm-P19: a novel amelogenin-derived peptide for enamel remineralization.Regenerative biomaterials · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
White spot lesions (WSLs) are early manifestations of enamel demineralization, commonly observed in orthodontic patients. Traditional fluoride therapies promote surface-level remineralization but often fall short in addressing subsurface mineral loss. Self-assembling peptides (SAPs), particularly P11-4, have emerged as biomimetic agents capable of penetrating lesions and facilitating deeper enamel regeneration. This systematic review aims to compare the remineralization potential of SAPs and fluoride agents in managing WSLs, evaluating both clinical efficacy and underlying mechanisms. Following Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines and registered in PROSPERO (CRD42024622963), an extensive literature search was conducted across PubMed, MEDLINE, Embase, Cochrane, Scopus, and grey literature from January 2000 to December 2024, which yielded 1,028 potential records. After screening 665 titles, 180 abstracts, and 60 retrieved full texts, seven clinical studies, all randomized or controlled clinical trials, met the eligibility criteria. Each study was assessed for risk of bias using the Cochrane RoB 2 tool, and evidence quality was evaluated using the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) approach. A meta-analysis was not performed due to methodological heterogeneity; therefore, results were synthesized narratively. SAP P11-4 demonstrated superior subsurface remineralization compared to fluoride in all included studies, with DIAGNOdent measurements showing reductions ranging from 23% to 41%. Combined SAP-fluoride therapy yielded enhanced outcomes. Although visual changes (International Caries Detection and Assessment System (ICDAS) scores) were often indistinguishable between groups, significant differences in mineral recovery were consistently reported. SAP P11-4 is a promising, minimally invasive alternative to fluoride for managing WSLs, especially in orthodontic patients. Its capacity for deep remineralization highlights its potential as a next-generation caries management tool. However, findings are based on short-term clinical trials, and further long-term randomized studies are recommended to validate and optimize clinical protocols.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.